FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF — Seattle, Washington

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF is a clinical research site located in Seattle, Washington, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF?

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF conducted?

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF accredited by Crixeo Health?

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.